BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15908680)

  • 1. The impact of hormone replacement therapy on the incidence of breast cancer in Norway.
    Bakken K; Lund E; Eggen AE
    J Clin Oncol; 2005 May; 23(15):3636-7; author reply 3637-8. PubMed ID: 15908680
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and mammographic screening.
    Marsden J
    J Br Menopause Soc; 2004 Jun; 10(2):75, 80. PubMed ID: 15207029
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of estrogen plus testosterone supplementation on breast cancer.
    Ness RB; Albano JD; McTiernan A; Cauley JA
    Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy: the right choice for your patient?
    Leong SL; Erickson DR; Pees RC
    J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901
    [No Abstract]   [Full Text] [Related]  

  • 6. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
    Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining breast cancer incidence and decreased HRT use.
    Suhrke P; Zahl PH; Maehlen J
    Lancet; 2009 Feb; 373(9662):460-1; author reply 461. PubMed ID: 19200913
    [No Abstract]   [Full Text] [Related]  

  • 9. Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy.
    Bouchardy C; Morabia A; Verkooijen HM; Fioretta G; Wespi Y; Schäfer P
    BMC Cancer; 2006 Mar; 6():78. PubMed ID: 16551373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 11. HRT advice.
    Cherry D
    Aust Fam Physician; 2002 Sep; 31(9):792. PubMed ID: 12402692
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of progestin in menopausal hormonal replacement therapy].
    Kauppila A
    Duodecim; 1996; 112(12):1097-103. PubMed ID: 10593011
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
    Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
    Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study.
    Suhrke P; Zahl PH
    Cancer Med; 2015 Aug; 4(8):1303-8. PubMed ID: 25991514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft.
    Lund E; Dumeaux V; Braaten T; Hjartåker A; Engeset D; Skeie G; Kumle M
    Int J Epidemiol; 2008 Feb; 37(1):36-41. PubMed ID: 17644530
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density.
    Conner P
    Ann Med; 2007; 39(1):28-41. PubMed ID: 17364449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer and the use of the hormones around the menopause].
    Mourits MJ; van der Zee AG
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):108; author reply 108-9. PubMed ID: 14753135
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy - where to from here? (with response from Sandra Coney).
    Fenton A
    N Z Med J; 2002 Sep; 115(1161):U163; discussion U163. PubMed ID: 12386670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.